PortfoliosLab logo

Alzamend Neuro, Inc. (ALZN)

Equity · Currency in USD · Last updated Sep 24, 2022

Company Info

ISINUS02262M3088
CUSIP02262M308
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$1.31
Year Range$0.82 - $3.08
EMA (50)$1.05
EMA (200)$1.38
Average Volume$520.91K
Market Capitalization$132.25M

ALZNShare Price Chart


Chart placeholderClick Calculate to get results

ALZNPerformance

The chart shows the growth of $10,000 invested in Alzamend Neuro, Inc. in Jun 2021 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $804 for a total return of roughly -91.96%. All prices are adjusted for splits and dividends.


-40.00%-30.00%-20.00%-10.00%0.00%10.00%AprilMayJuneJulyAugustSeptember
-14.56%
-20.26%
ALZN (Alzamend Neuro, Inc.)
Benchmark (^GSPC)

ALZNReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M14.81%-10.55%
6M-12.50%-18.29%
YTD-42.89%-22.51%
1Y-54.03%-15.98%
5Y-86.10%-10.35%
10Y-86.10%-10.35%

ALZNMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-19.47%-22.88%4.24%-17.07%-7.65%-8.28%2.89%1.80%19.89%
2021-35.26%-49.37%-30.85%0.65%-30.52%-0.00%-11.21%

ALZNSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Alzamend Neuro, Inc. Sharpe ratio is -0.60. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.80-0.60-0.40-0.20Jun 19Jun 26Jul 03Jul 10Jul 17Jul 24Jul 31Aug 07Aug 14Aug 21Aug 28Sep 04Sep 11Sep 18
-0.60
-0.78
ALZN (Alzamend Neuro, Inc.)
Benchmark (^GSPC)

ALZNDividend History


Alzamend Neuro, Inc. doesn't pay dividends

ALZNDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugustSeptember
-91.96%
-23.00%
ALZN (Alzamend Neuro, Inc.)
Benchmark (^GSPC)

ALZNWorst Drawdowns

The table below shows the maximum drawdowns of the Alzamend Neuro, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Alzamend Neuro, Inc. is 93.93%, recorded on Jun 16, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-93.93%Jun 16, 2021254Jun 16, 2022

ALZNVolatility Chart

Current Alzamend Neuro, Inc. volatility is 104.90%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%140.00%AprilMayJuneJulyAugustSeptember
104.90%
23.28%
ALZN (Alzamend Neuro, Inc.)
Benchmark (^GSPC)